A proposal for the withdrawal of inhaled corticosteroids in the clinical practice of chronic obstructive pulmonary disease

According to the current clinical practice guidelines for chronic obstructive pulmonary disease (COPD), the addition of inhaled corticosteroids (ICS) to long-acting β(2) agonist therapy is recommended in patients with moderate-to-severe disease and an increased risk of exacerbations. However, ICS ar...

Descripción completa

Detalles Bibliográficos
Autores principales: Miravitlles, Marc, Cosío, Borja G., Arnedillo, Aurelio, Calle, Myriam, Alcázar-Navarrete, Bernardino, González, Cruz, Esteban, Cristóbal, Trigueros, Juan Antonio, Rodríguez González-Moro, José Miguel, Quintano Jiménez, José Antonio, Baloira, Adolfo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5706374/
https://www.ncbi.nlm.nih.gov/pubmed/29183382
http://dx.doi.org/10.1186/s12931-017-0682-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5706374/
https://www.ncbi.nlm.nih.gov/pubmed/29183382
http://dx.doi.org/10.1186/s12931-017-0682-y

Ejemplares similares